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Abstract
Background:  Fine needle aspiration biopsy (FNAB) cytology has been a highly effective
methodology for tissue diagnosis and for various ancillary studies including molecular tests. In
addition to other benefits, FNAB predominantly retrieves the diagnostic loosely cohesive cells in
the lesion as compared to the adjacent supporting stroma with relatively higher cohesiveness.
However, FNAB procedure performed with currently available resources is highly skill dependent
with inter-performer variability, which compromises its full potential as a diagnostic tool. In this
study we report a device overcoming these limitations.
Methods: 'Tissue Harvester with Functional Valve' (THFV) was evaluated as part of a phase 1
National Institute of Health (NIH) research grant under Small Business Technology Transfer
(STTR) Program. Working prototypes of the device were prepared. Each of the four
cytopathologists with previous cytopathology fellowship training and experience in performing
FNAB evaluated 5 THFV and 5 hypodermic needles resulting in 40 specimens (20 with THFV, 20
with hypodermic needles). A piece of fresh cattle liver stuffed in latex glove was used as the
specimen. Based on these results a finished design was finalized.
Results: The smears and cell blocks prepared from the specimens obtained by THFV were
superior in terms of cellularity to specimens obtained with hypodermic needles. The tissuecrit of
specimens obtained with THFV ranged from 70 to 100 μl (mean 87, SD 10), compared to 17 to 30
μl (mean 24, SD 4) with conventional hypodermic needles (p < .0001, Student t-test). The technical
ease [on a scale of 1 (easy) to 5 (difficult)] with THFV ranged from 1 to 2 as compared to 2 to 3
with hypodermic needles.
Conclusion: The specimen yield with the new THFV was significantly higher when compared to
hypodermic needles. Also, the FNAB procedure with THFV was relatively easier in comparison
with hypodermic needles. The final version of Shidham's THFV device would improve the FNAB
specimen yield by eliminating the skill factor. The increased specimen yield by this device would
also facilitate wider application of FNAB specimens for various ancillary tests, including molecular
tests.
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Background
Fine Needle Aspiration Biopsy (FNAB) is a safe, rapid, eco-
nomical, and minimally invasive non-surgical technique
for tissue diagnosis of various tumors and lesions [1-15].
It is widely performed around the world including in
more than six thousand hospitals in the United States
[16,17]. FNAB is a procedure in which a fine gauge needle
(ranging from 18G to 25G, preferably 23 to 25G) is
inserted into a lesion and moved in multiple directions
for wider sampling, usually under vacuum, to retrieve
cells and microfragments of tissue (Figure 1 A through D).
Due to the non-availability of special FNAB needles, con-
ventional hypodermic needles or their minor modified
versions have to be used to perform the procedure. The
limitations of conventional needles include inherent defi-
ciencies in their design, and the requirement of greater
technical skill, which leads to a higher frequency of unsat-
isfactory results, and a relatively low specimen yield.
One of the major limiting factors of a conventional hypo-
dermic needle is the narrow diameter and low volume of
the hub (Figure 1D). This restricts the quantity of speci-
men material that can accumulate in the hub at the end of
the FNAB procedure without entering the syringe. If the
scant material entering the syringe spreads along the
syringe barrel wall, it cannot be retrieved properly for
preparation of direct smears for cytopathologic evalua-
tion. Accordingly, it is important for the performer to be
aware of the material entering the syringe and stop the
procedure at that time. These factors contribute to qualita-
tively and quantitatively poor diagnostic material with a
higher proportion of unsatisfactory results.
Special syringe grips (Figure 1A-C) further increase the
complexity of the procedure [18]. Thus, due to the lack of
a commercially available suitable device for performing
FNAB, this widely used valuable technique suffers signifi-
cant shortcomings with lower reproducibility because of
variable skills and success rates.
Depending on initial cytopathologic evaluation, addi-
tional ancillary tests such as flow cytometry, molecular
techniques, cytogenetics, microbiology cultures, fluores-
cent in-situ hybridization, electron microscopy, cell block
for immunocytochemistry, or other tests may be indi-
cated. With currently available methods, this requires that
additional passes be performed to obtain more sample.
This increases patient discomfort and leads to higher uti-
lization of disposables.
The aim of this study was to prepare the device prototype
and evaluate the efficiency of the initial design for speci-
men retrieval (Figure 2). The evaluation of efficiency
included comparison with the traditional method. Based
on the experience with the prototype, the final design for
mass production was refined further at the end of the
study.
Methods
As part of a phase 1 NIH research grant under Small Busi-
ness Technology Transfer (STTR) Program, the novel
design of THFV by authors VS and AS was evaluated by
cytopathology fellowship trained cytopathologists [19].
Rapid prototypes (Figures 3 and 4) of THFV device were
prepared by Stereolithography (SLA) after critical evalua-
tion of three dimensional computer assisted design
(CAD) using SolidWorks® software (SolidWorks Corpora-
tion, Concord, MA). Working prototypes of clear poly-
urethane were prepared using Silicone RTV molds set
around SLA masters (Figure AF3 in Additional file #1).
Each cytopathologist (VS,AP,RNR,ZB) evaluated 5 work-
ing models of THFV devices (Figure 4) and compared the
results with 5 hypodermic needles by the same
cytopathologists. This generated 20 FNABs by THFV
devices and 20 by hypodermic needles. A piece of fresh
cattle liver procured from the local slaughter house was
stuffed in latex glove and were used as specimens. Cellu-
larity of direct smears, Tissuecrit of the needle rinses, and
technical ease of performing the procedure were com-
pared.
Evaluation of the specimen yield of the working models to 
demonstrate the feasibility of the invention
Various steps during the procedure with the conventional
hypodermic needle and with the new needle device are
shown in Figure 1. The procedure for performing the
FNAB with the working model of Shidham's THFV is as
follows:
(a) Assemble the needle hub, the coupler with tap like
valve, and the syringe as shown in Figure 3g2 and 4d.
(b) Close the tap like valve (Figure 3g3).
(c) Create vacuum in the syringe barrel by pulling the
syringe piston, which locks itself in the pulled position
(Figure 3g3).
(d) Grip the needle device like a pencil at the wide mouth
hub (Figure 1M-O).
(e) Insert the needle into the lesion to be sampled under
routine aseptic precautions.
(f) Once the needle is in the lesion, open the tap like valve
of the coupler to facilitate the suction effect of the vacuum
in the syringe to reach up to the needle tip.BMC Clinical Pathology 2007, 7:2 http://www.biomedcentral.com/1472-6890/7/2
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Comparison of FNAB procedures by hypodermic needle and THFV Figure 1
Comparison of FNAB procedures by hypodermic needle and THFV.
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Initial design for planning three dimensional CAD Figure 2
Initial design for planning three dimensional CAD.BMC Clinical Pathology 2007, 7:2 http://www.biomedcentral.com/1472-6890/7/2
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Three dimensional CAD as initial step towards preparation of SLA prototype Figure 3
Three dimensional CAD as initial step towards preparation of SLA prototype.
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(g) Push the needle back and forth into the lesion in dif-
ferent directions for optimal sampling of the lesion till
enough material accumulates in the transparent wide-
mouth hub (Figure 1N).
(h) Close the tap like valve of the coupler to disconnect
the vacuum in the syringe from the needle.
(i) Remove the needle from the lesion and park the needle
into the cap cum stand-like cradle without holding the
stand with hand to avoid needle prick injury. The needle
fits into the cap-cum-stand (Figure 3g4).
(j) Disengage the wide mouth hub of the needle from the
coupler by holding the grip area on the hub (Figures 3g5)
with the needle in the cap cum stand.
(k) Transfer the representative sample by inverting the
capped needle gently on the glass slide or by using a fine
tip forceps to transfer the microfragments from wide
mouth hub with 'pick and smear' method [20]. During
this, the needle could be parked in upright position in the
cap cum stand (Figure 1P1,P2) with wide base (Figures
1P2, 3g, and 5d).
The remaining specimen in the wide mouth hub was
rinsed with Cytorich for estimation of Tissuecrit, which is
the volume of tissue microfragments. The needle hub was
rinsed with a constant volume (300 μl) of CytoRich Red®
fixative (AutoCyte Inc, Elon College, NC) for cell block
preparation after preparing direct cytology smears. The tis-
sue micro-fragments were compacted as sediments under
gravity for 60 minutes and the volume of the tissue frag-
ments was noted (Figure 5).
Working prototype to be evaluated in the study Figure 4
Working prototype to be evaluated in the study.
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Cellularity of the direct smears with the new needle was
evaluated semi-quantitatively (hypocellular- very few
scattered cells, mild- <20% area in the field covered by
cells in the specimen, moderate- 20% to 50% area in the
field covered by cells in the specimen, and marked- >50%
area in the field covered by cells in the specimen). The
technical ease of performing the procedure was also noted
by each pathologist on a scale of 1 (easy) to 5 (difficult).
Results
The Tissuecrit of specimens obtained with THFV ranged
from 70 to 100 μl (mean 87, SD 10) as compared to 17 to
30 μl (mean 24, SD 4) with SN (p < .0001, Student t-test).
Table 1: Comparison of results of the new THFV with those with conventional hypodermic needles.
Feature New FNAB needle device (5 by each of 4 CP-Total 20) Hypodermic needle (5 by each of 4 CP-Total 20)
Cellularity of direct smears Moderate to marked (Figure 6c) Mild to hypocellular (Figure 6f)
Density of tissue fragments in cell block Moderate to marked (Figure 6a,b) Mild to hypocellular (Figure 6d,e)
Tissuecrit¶ (Figure 5) 70–100 μl (Mean 87, SD 10)* 17–30 μl (Mean 24, SD 4)*
Technical ease§ 1–2 2–3
DS, direct smear, CP, cytopathologists, SD, standard deviation.
¶Volume of tissue microfragments procured with FNAB procedure and rinsed in CytoRich Red® fixative (AutoCyte Inc, Elon College, NC) for cell 
block preparation after preparing direct cytology smears. The tissue microfragments were compacted as sediments under gravity for fixed duration 
(Figure 5).
*p value < .0001, Student t-test.
§Scale of 1 (easy) to 5 (difficult).
Comparison of Tissuecrits Figure 5
Comparison of Tissuecrits.
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Tissuecrit (Figure 5) showed a higher yield with the new
needle device when compared to the FNAB results with
conventional hypodermic needles and demonstrated the
feasibility of the invention (Table 1). The smears (Figure
6 c&f; 7) and cell blocks (Figure 6 a,b & d,e; 7) prepared
from the specimens obtained by THFV were uniformly
hypercellular as compared to mostly hypocelluar with
hypodermic needles. The technical ease with THFV ranged
from 1 to 2 as compared to 2 to 3 with hypodermic nee-
dles.
Perforations with the 45 degree bevel at the tip of the nee-
dle did not demonstrate any significant advantage with
results compared to those achieved with needles without
perforation in needle wall near the tip of the needle (Table
AF1 #2 in Additional file #1). This feature was not consid-
ered a significant benefit in return for the cost and was
removed in the final design.
Discussion
The Shidham's THFV procured a significantly higher yield
of FNAB specimen as compared to hypodermic needles. It
demonstrated relatively superior technical ease as com-
pared to hypodermic needles. The details of the new nee-
dle device are shown in Figure 2. A schematic
representation of the procedures performed using THFV
and a conventional hypodermic needle is shown in Figure
1. The mechanism of THFV is depicted in a brief anima-
tion (additional file 2).
The FNAB procedure is the method of choice for mini-
mally invasive retrieval of tissue material from a patient
for tissue diagnosis and other tests [21]. In contrast to
FNAB, surgical operation requires special conditions such
as an operating room, skilled surgical professionals, and
supporting ancillary services. Furthermore, surgical
biopsy also adds financial burden, pain, scarring, risk of
complications, and loss of man hours with the invariable
disruption of the personal schedule of the patient under-
going surgical biopsy. Many of the limitations of a surgical
biopsy can be avoided by FNAB, which can be performed
under general settings such as in the doctor's office. How-
ever, performing FNAB by conventional hypodermic nee-
dle with or without application of vacuum is associated
Gross comparison of cellularity in cell-block and cytology smears Figure 6
Gross comparison of cellularity in cell-block and cytology smears.
Cell block Cell block section Cytology smear
Conventional hypodermic needle
a b c
Cell block Cell block section Cytology smear
d e fBMC Clinical Pathology 2007, 7:2 http://www.biomedcentral.com/1472-6890/7/2
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with limitations of lower tissue yield which is usually
insufficient for performing ancillary studies.
Many ancillary tests and evolving molecular techniques
such as microarray and proteomics [13,22-24] require
procurement of tissue specimens at various stages of man-
agement. It is critical to provide a reproducible procedure
for such retrieval. THFV device would facilitate easily
reproducible sampling with the added benefit of onsite
cytologic evaluation to confirm the adequacy of specimen
for the test to be performed. In addition to clinical appli-
cations, this device could also be used for precise harvest-
ing of tissue for research from various specimens under
aseptic conditions.
Although the modified version of the hypodermic needle
with an elongated hub may allow slightly more specimen
yield, it does not retain the entire specimen retrieved dur-
ing the process. A significant portion of specimen in the
needle and hub is lost back due to negative pressure and
capillary action while withdrawing the needle from the
lesion during the last step. Similar limitations apply to
slightly modified hypodermic needles having a perforated
tip.
Once the specimen is retrieved, it is preferably examined
immediately on site for adequacy evaluation with prelim-
inary interpretation. A 'pick and spread' method allows
smearing of selected material on the glass slide [20]. Due
to the narrow mouth of the needle hub, hypodermic nee-
dles or their modified versions do not allow easy picking
of micro-fragments in the specimen by fine tip forceps
directly from the needle hub. The current device with
wider hub allowed 'pick and spread' approach [20]. Based
on the observations during this study [19] the design was
finalized for the molds required for the mass production
of "Shidhams' THFV device" (Figure 8).
Microscopic comparison of cellularity in cell-block and cytology smears Figure 7
Microscopic comparison of cellularity in cell-block and cytology smears.
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Conclusion
The new THFV device procured a significantly higher yield
of FNAB specimen as compared to hypodermic needles. It
demonstrated relatively superior technical ease as com-
pared to hypodermic needles. This is a novel device for
procurement of tissue for molecular tests and tissue diag-
nosis by various methods including cytopathology.
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Final SLA model prepared after incorporating modifications based on the current study Figure 8
Final SLA model prepared after incorporating modifications based on the current study. Note that in final model coupler and 
valve are combined as one unit (a,b,d). Complete assembly is shown in b.
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